HUTCHMED (China) (HCM) Receivables - Other (2015 - 2025)
HUTCHMED (China) (HCM) reported Receivables - Other of $21.5 million for Q2 2025, up 46.11% year-over-year from $14.7 million in Q2 2024, and up 46.11% quarter-over-quarter from $14.7 million in Q2 2024.
HUTCHMED (China) (HCM) Receivables - Other (2015 - 2025) Analysis & Trends
HUTCHMED (China) (HCM) has 11 years of Receivables - Other data on file, last reported at $21.5 million in Q2 2025.
- Receivables - Other for Q2 2025 came in at $21.5 million, up 46.11% year-over-year; the trailing twelve-month figure through Jun 2025 was $21.5 million (up 46.11% YoY), and the FY2025 annual result was $21.8 million, up 175.64% from the prior year.
- Receivables - Other improved to $21.5 million in Q2 2025 per HCM's latest filing, from $14.7 million in the prior quarter.
- Over five years, Receivables - Other peaked at $73.0 million in Q2 2022 and troughed at $14.7 million in Q2 2024.
- A 5-year average of $34.1 million and a median of $29.3 million in 2023 frame the typical range for Receivables - Other.
- The sharpest annual moves came in 2022 and 2023: Receivables - Other soared 127.39% in 2022, then sank 59.91% in 2023.
- A 5-year view of Receivables - Other shows it stood at $32.1 million in 2021, then soared by 127.39% to $73.0 million in 2022, then slumped by 59.91% to $29.3 million in 2023, then tumbled by 49.75% to $14.7 million in 2024, then surged by 46.11% to $21.5 million in 2025.
- Business Quant data shows HCM's Receivables - Other at $21.5 million in Q2 2025, $14.7 million in Q2 2024, and $29.3 million in Q2 2023.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn |
| 10 | HUTCHMED (China) | 1.16 Bn | -306.90 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 21.50 Mn |
| Jun 30, 2025 | 21.50 Mn |
| Jun 30, 2024 | 14.71 Mn |
| Jun 30, 2024 | 14.71 Mn |
| Jun 30, 2023 | 29.28 Mn |
| Jun 30, 2023 | 29.28 Mn |
| Jun 30, 2022 | 73.03 Mn |
| Jun 30, 2022 | 73.03 Mn |
| Jun 30, 2021 | 32.12 Mn |
| Jun 30, 2021 | 32.12 Mn |
| Dec 31, 2020 | -9.60 Mn |
| Dec 31, 2020 | -9.60 Mn |
| Jun 30, 2020 | 17.50 Mn |
| Jun 30, 2020 | 17.50 Mn |
| Dec 31, 2019 | -2.73 Mn |
| Dec 31, 2019 | -2.73 Mn |
| Dec 31, 2018 | 2.39 Mn |
| Dec 31, 2018 | 2.39 Mn |
| Jun 30, 2018 | 14.32 Mn |
| Jun 30, 2018 | 14.32 Mn |